Safety and Effectiveness of the PXL-Platinum 330 System

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    Colorado Eye Consultants/Cornea Consultants of Colorado
Updated on 19 February 2024
keratoconus
riboflavin
radial keratotomy
terrien's marginal degeneration

Summary

To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.

Description

Patients with progressive keratoconus, pellucid marginal degeneration, or at risk for post-refractive corneal ectasia will be recruited and undergo epithelial-on corneal crosslinking with the Peschke PXL-330 system using pulsed, accelerated energy delivery. Patients will undergo monitoring for 1 year, with serial measurements of corneal topography, visual acuity, intraocular pressure, and pachymetry.

Details
Condition Keratoconus, Corneal Ectasia, Pellucid Marginal Corneal Degeneration
Age 8years - 100years
Treatment PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
Clinical Study IdentifierNCT04401865
SponsorColorado Eye Consultants/Cornea Consultants of Colorado
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Diagnosis of keratoconus, forme fruste keratoconus, post-LASIK ectasia, pellucid marginal degeneration, forme fruste pellucid marginal degeneration, history of radial keratotomy with fluctuating vision, Terrien's marginal degeneration
Must have provided informed consent, documented it in writing, and have been given a copy of the signed informed consent form
Must be willing and able to return for scheduled treatment and follow-up examinations for the duration of the study
Must be at least 8 years of age
Non-consenting/impaired individuals with a LAR's signature

Exclusion Criteria

Corneal thickness < 300 microns measured by ultrasound or Pentacam
Contraindications or sensitivities to any study medications or their components
Pregnancy or breastfeeding
Any history of Herpes simplex corneal disease in an eye to be treated
Nystagmus or any other condition that would, in the judgement of the investigator, prevent a steady gaze during the treatment
Inability to cooperate with diagnostic tests
Current enrollment in another ophthalmic clinical trial
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study AnnotationsStudy Notes

Notes added here are public and can be viewed by anyone. Notes added here are only available to you and those who you share with.

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.